DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
50 hedge funds and large institutions have $32.4M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.06M | |
| 2 | +$308K | |
| 3 | +$287K | |
| 4 |
Renaissance Technologies
New York
|
+$244K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$144K |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$839K | |
| 3 | -$758K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$701K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$470K |